Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00115609 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients With Tuberculosis (ANRS129)

StatusCompleted
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Publications expanded, about 67 wordsv15 See this version in full on ClinicalTrials.gov ↗
  2. Re-verified, no change to tracked fieldsv14
  3. Trial status: Active, Not Recruiting to Completed Primary and study completion dates changed from estimate of Dec 2009 to Nov 2009v13 Show 1 more changeShow less
    • Primary and study completion dates changed from estimate of Dec 2009 to Nov 2009
  4. Primary endpoints: 3 to 1 Enrollment target: estimated 100 to confirmed 70 · Interventions: efavirenz (Drug), emtricitabine (Drug), tenofovir (Drug) to efavirenz (Drug), emtricitabine (Drug), tenofovir DF (Drug) · Secondary endpoints revised (10)v12 Show 3 more changesShow less
    • Enrollment target: estimated 100 to confirmed 70
    • Interventions: efavirenz (Drug), emtricitabine (Drug), tenofovir (Drug) to efavirenz (Drug), emtricitabine (Drug), tenofovir DF (Drug)
    • Secondary endpoints revised (10)

    See this version in full on ClinicalTrials.gov ↗

  5. Study title expanded, about 1 wordv11 See this version in full on ClinicalTrials.gov ↗
Show 9 earlier versionsHide 9 earlier versions
  1. Trial status: Recruiting to Active, Not Recruiting Primary and study completion dates: Dec 2009 · Site details revisedv10 Show 2 more changesShow less
    • Primary and study completion dates: Dec 2009
    • Site details revised
  2. 4 versions Re-verified since Aug 28, 2006, no change to tracked fieldsv6-v9
  3. Trial status: Not Yet Recruiting to Recruiting Start date: Jan 2006 · Site details revisedv5 Show 2 more changesShow less
    • Start date: Jan 2006
    • Site details revised
  4. Study Identification, Study Statusv4
  5. 2 versions Re-verified since Jul 18, 2005, no change to tracked fieldsv2-v3
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Successful therapy of both tuberculosis and HIV disease share similar problems: pill burden, drug interaction, adherence challenge and toxicity. This study will test the efficacy and safety of a once daily antiretroviral regimen in HIV-tuberculosis coinfected patients.
Trial Details
NCT Number NCT00115609
Lead Sponsor French National Agency for Research on AIDS and Viral Hepatitis
Conditions HIV Infections, Tuberculosis
Enrollment 70 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov